3D Biomatrix, a leader in three-dimensional (3D) cell culture products, announced its selection as runner-up in the Medicine and Biotech category in the 2012 Wall Street Journal Technology Innovation Awards. The company was chosen among 536 entries from over two dozen countries by an independent panel of judges, with only 7% of entries winning an award. 3D Biomatrix was recognized for the development of its Perfecta3D hanging drop plates, which are designed to allow researchers to perform cell culture in a 3D environment, as the human body is 3D, rather than a conventional 2D environment such as a flat Petri dish.
The Perfecta3D Hanging Drop Plates help researchers focused on cancer research and drug development, toxicology testing, and stem cell research to easily grow cells in small spherical 3D clusters called spheroids. Spheroids are one of the most well characterized models for 3D culture and screening due to their simplicity and similarity to human tissues, and until now, have been difficult to work with without large expense. The 3D Hanging Drop Plates make spheroid formation and testing easy and consistent in a familiar 96- and 384-well plate format.
Consistent and controllable 3D cell cultures allow pharmaceutical researchers to obtain more physiological data earlier in the testing process. “3D cell cultures can have a high impact on the pharmaceutical industry and human health by reducing the cost and time of taking a drug to market, and it is a great step forward to have this recognized by the business community,” said 3D Biomatrix CEO Laura Schrader. “We are thrilled to be recognized alongside other highly inventive companies in receiving this award for innovation from the Wall Street Journal.”
Date: October 18, 2012
Source: 3D Biomatrix
Filed Under: Drug Discovery
